導(dǎo)師簡(jiǎn)介

姓名:魏志剛性別:男 政治面貌:群眾學(xué)歷:博士
學(xué)位:研究生職稱:主任醫(yī)師
博,、碩導(dǎo)師: 博士,、碩士導(dǎo)師本崗位工作年數(shù):27年:
研究方向:肝膽胰腫瘤及常見疾病的微創(chuàng)外科治療
肝膽胰腫瘤的發(fā)生發(fā)展研究
榮譽(yù)稱號(hào):山西省衛(wèi)生計(jì)生委百千萬衛(wèi)生人才培養(yǎng)工程高端領(lǐng)軍人才、山西省優(yōu)秀醫(yī)師,、三晉好醫(yī)生,、先進(jìn)工作者等榮譽(yù)稱號(hào)。
學(xué)術(shù)任職:現(xiàn)任中華醫(yī)學(xué)會(huì)外科分會(huì)青年委員會(huì)委員,、中國(guó)醫(yī)師協(xié)會(huì)機(jī)器人醫(yī)師分會(huì)委員,、國(guó)際肝膽胰協(xié)會(huì)中國(guó)分會(huì)肝血管瘤專業(yè)委員會(huì)委員、中國(guó)研究型醫(yī)院學(xué)會(huì)微創(chuàng)外科專業(yè)委員會(huì)委員,、中國(guó)醫(yī)療保健國(guó)際交流促進(jìn)會(huì)肝臟移植分會(huì)委員,、中國(guó)醫(yī)學(xué)裝備協(xié)會(huì)外科醫(yī)學(xué)裝備分會(huì)基礎(chǔ)研究裝備專業(yè)委員會(huì)委員、山西省醫(yī)學(xué)會(huì)外科分會(huì)副主任委員,、山西省醫(yī)師協(xié)會(huì)外科醫(yī)師分會(huì)副會(huì)長(zhǎng),,山西省醫(yī)學(xué)會(huì)器官移植學(xué)專業(yè)委員會(huì)副主任委員等。
近五年承擔(dān)科研課題情況:
例如:山西省科技廳重點(diǎn)研發(fā)計(jì)劃項(xiàng)目 項(xiàng)目名稱:G型入路機(jī)器人胰十二指腸切除術(shù)治療壺腹部腫瘤的臨床療效分析,,項(xiàng)目編號(hào): 201903D321144
代表性論著及近五年的代表性論文(限10項(xiàng)以內(nèi)):
例如:
1.Wei ZG, Liang CJ, Du Y, Zhang YP, Liu Y. Learning curve for a surgeon in robotic pancreaticoduodenectomy through a "G"-shaped approach: A cumulative sum analysis. World J Clin Cases. 2022 May 16;10(14):4357-4367. doi: 10.12998/wjcc.v10.i14.4357.
2.Zhao Q, Wang Y, Huo T, Li F, Zhou L, Feng Y, Wei Z. Exploration of Risk Factors for Pancreatic Cancer and Development of a Clinical High-Risk Group Rating Scale. J Clin Med. 2023 Jan 2;12(1):358. doi: 10.3390/jcm12010358.
3.Guo J, Wang Y, Hou J, Zhao T, Wei Z. Comprehensive analysis of disulfidptosis-related lncRNAs for predicting prognosis and response of immunotherapy in pancreatic adenocarcinoma. Transl Cancer Res. 2024 Mar 31;13(3):1336-1350. doi: 10.21037/tcr-23-1706. Epub 2024 Mar 27. PMID: 38617527; PMCID: PMC11009799.
4.Zhang Y, Yang Y, Qi X, Cui P, Kang Y, Liu H, Wei Z, Wang H. SLC14A1 and TGF-β signaling: a feedback loop driving EMT and colorectal cancer metachronous liver metastasis. J Exp Clin Cancer Res. 2024 Jul 27;43(1):208. doi: 10.1186/s13046-024-03114-8. PMID: 39061061; PMCID: PMC11282742.
5.Zhang Y, Wei R, Bai L, Jiao S, Milano MT, Liu H, Wei Z. The onset characteristics and prognosis of patients with radiation-associated second primary malignancy: a pancancer study in the US SEER cancer registries. Transl Cancer Res. 2024 Oct 31;13(10):5588-5599. doi: 10.21037/tcr-24-1618. Epub 2024 Oct 29. PMID: 39525022; PMCID: PMC11543024.
6.Liang C, Shan D, Wei Z. PDO-Based Drug Screening in Advanced Pancreatic Cancer. Gastroenterology. 2025 Mar;168(3):627-628. doi: 10.1053/j.gastro.2024.10.045. Epub 2024 Nov 19. PMID: 39571820.
7.Wei Z, Shan D, Liang C. Does MASH comorbidity in CHB truly suppress immune function? J Hepatol. 2024 Nov 8:S0168-8278(24)02698-9. doi: 10.1016/j.jhep.2024.11.002. Epub ahead of print. PMID: 39522882.